Influenza cases surge in China, driving up demand and price for antiviral drug Xofluza.

Cases of seasonal influenza in China have surged, boosting demand for the antiviral drug Xofluza (baloxavir marboxil). Approved for use in adults and children aged 5 and above, the drug's price has risen on e-commerce platforms. Health experts caution against hoarding the medication and administering it without a doctor's advice. Roche, the sole supplier in China, assures there is sufficient stock available.

2 months ago
4 Articles

Further Reading